Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancersin vivoand impacts viability and proliferationin vitro-Reference-Cited by-同舟云学术

Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancersin vivoand impacts viability and proliferationin vitro

Published:2007-06-03 Issue:2 Volume:1 Page:181-195
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Birkenkamp-Demtroder Karin,Mansilla Francisco,Sørensen Flemming Brandt,Kruhøffer Mogens,Cabezón Teresa,Christensen Lise Lotte,Aaltonen Lauri A.,Verspaget Hein W.,Falck Ørntoft Torben

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference41 articles.

1. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells;Archer;Proc. Natl. Acad. Sci. U.S.A.,1998

2. Microsatellite instability and colorectal cancer prognosis;Benatti;Clin. Cancer Res.,2005

3. Gene expression in colorectal cancer;Birkenkamp-Demtroder;Cancer Res.,2002

4. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid;Birkenkamp-Demtroder;Gut.,2005

5. Secretagogin is a novel marker for neuroendocrine differentiation;Birkenkamp-Demtroder;Neuroendocrinology,2005

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRT23 acts as an oncogene in hepatocellular carcinoma by regulating PI3K/AKT/GSK3β pathway via P21;2024-08-07

2. The Identification of RPL4 as a Hub Gene Associated with Goat Litter Size via Weighted Gene Co-Expression Network Analysis;Animals;2024-05-15

3. The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers;2023-11-17

4. Dynamic changes in protein concentrations of keratins in crop milk and related gene expression in pigeon crops during different incubation and chick rearing stages;British Poultry Science;2022-11-07

5. Combined targeting of KRT23 and NCCRP1 as a potential novel therapeutic approach for the treatment of triple-negative breast cancer;Gland Surgery;2022-10